Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users

被引：0
|
作者：
Merete Ellingjord-Dale
Eunjung Lee
Elisabeth Couto
Ali Ozhand
Samera Azeem Qureshi
Solveig Hofvind
David J Van Den Berg
Lars A Akslen
Tom Grotmol
Giske Ursin
机构：
[1] University of Oslo,Department of Nutrition
[2] University of Southern California,Department of Preventive Medicine, Keck School of Medicine
[3] Cancer Registry of Norway,Department of Medical Epidemiology and Biostatistics
[4] Karolinska Institutet,The Gade Institute, Section for Pathology
[5] Oslo and Akershus University College of Applied Sciences,undefined
[6] University of Bergen,undefined
来源：
Breast Cancer Research | / 14卷
关键词：
Hormone Therapy; Breast Cancer Risk; Mammographic Density; Breast Cancer Risk Factor; Percent Density;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Pre-existing risk factor profiles in users and non-users of hormone replacement therapy:: prospective cohort study in Gothenburg, Sweden (vol 319, pg 890, 1999)
    Rödström, K
    BRITISH MEDICAL JOURNAL, 2003, 327 (7428): : 1381 - 1381
  • [42] Pre-existing risk factor profiles in users and non-users of hormone replacement therapy:: prospective cohort study in Gothenburg, Sweden (vol 319, pg 890, 1999)
    Rödström, K
    BRITISH MEDICAL JOURNAL, 1999, 319 (7222): : 1429 - 1429
  • [43] The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving hormone therapy
    Ito, Roberto Sano
    CLIMACTERIC, 2010, 13 (02) : 199 - 200
  • [44] Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05): : 875 - 884
  • [45] Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer
    Diergaarde, Brenda
    Potter, John D.
    Jupe, Eldon R.
    Manjeshwar, Sharmila
    Shimasaki, Craig D.
    Pugh, Thomas W.
    DeFreese, Daniele C.
    Gramling, Bobby A.
    Evans, Ilonka
    White, Emily
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (07) : 1751 - 1759
  • [46] Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer
    Razavi, Pedram
    Lee, Eunjung
    Bernstein, Leslie
    Van Den Berg, David
    Horn-Ross, Pamela L.
    Ursin, Giske
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (07) : 1629 - 1638
  • [47] Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland
    Koskela-Niska, Virpi
    Riska, Annika
    Lyytinen, Heli
    Pukkala, Eero
    Ylikorkala, Olavi
    GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 241 - 244
  • [48] RISK OF BREAST CANCER AMONG USERS OF POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY IN TAIWAN
    Shen, W. C.
    Lin, M. S.
    Bai, C. H.
    Chen, W. C.
    Tang, C. H.
    VALUE IN HEALTH, 2010, 13 (07) : A511 - A511
  • [49] Postmenopausal bleeding: Which endometrial thickness is safe in menopausal hormone therapy users?
    Dreisler, Eva
    CASE REPORTS IN WOMENS HEALTH, 2022, 35
  • [50] Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study
    Eunjung Lee
    Jianning Luo
    Yu-Chen Su
    Juan Pablo Lewinger
    Fredrick R Schumacher
    David Van Den Berg
    Anna H Wu
    Leslie Bernstein
    Giske Ursin
    Breast Cancer Research, 16
12345